We are live on ! Find out more
DVF

Discovery Value Fund Portfolio holdings

AUM $34.7M
1-Year Est. Return 58.56%
This Fund
S&P 500
This Quarter Est. Return
-6.49%
1 Year Est. Return
+58.56%
3 Year Est. Return
+207.12%
5 Year Est. Return
+65.96%
10 Year Est. Return
–
AUM
$34.7M
AUM Growth
-$2.81M
Cap. Flow
-$416K
Cap. Flow %
-1.2%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
1

Top Buys

1
NVDA icon
NVIDIA
NVDA
+$465K

Top Sells

1
NTLA icon
Intellia Therapeutics
NTLA
+$881K

Sector Composition

1 Technology 100%
2 Healthcare 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.91T
$34.7M 100%
198,874
+2,533
+1% +$465K
NTLA icon
2
Intellia Therapeutics
NTLA
$1.59B
– –
-97,976
Closed -$881K

Similar funds

VVVM4
Viola Ventures VC Management 4 Herzliya, Israel $34.8M AUM 55.16% 1-Year Est. Return
IA
IFG Advisory Atlanta, Georgia $34.9M AUM 20.48% 1-Year Est. Return
CWM
Consultiva Wealth Management San Juan, Puerto Rico $34.5M AUM 31.52% 1-Year Est. Return
CPR
CSU Producer Resources Fairfield, Ohio $34.9M AUM 30.77% 1-Year Est. Return
RF
Roberts Foundation San Mateo, California $34.4M AUM 10.45% 1-Year Est. Return
ACM
Altai Capital Management West Hollywood, California $35M AUM 28.16% 1-Year Est. Return
AP
Atairos Partners Bryn Mawr, Pennsylvania $35.2M AUM 32.88% 1-Year Est. Return
MAM
Madryn Asset Management New York $34.1M AUM

Discovery Value Fund's Q1 2026 Portfolio in Review

As of Q1 2026, Discovery Value Fund held 2 positions worth $34.7M, down 7.5% from $37.5M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Discovery Value Fund's Q1 2026 filing shows 1 increased and 1 closed positions. The largest sale was Intellia Therapeutics, an estimated $881K.

By sector, the portfolio is most concentrated in Technology at 100% of assets, up from 98% a quarter earlier, followed by Healthcare.

  • Discovery Value Fund added most to NVIDIA in Q1 2026, an estimated $465K increase.
  • Discovery Value Fund fully exited Intellia Therapeutics in Q1 2026, selling an estimated $881K.
  • Discovery Value Fund's ten largest holdings make up 100% of its $34.7M portfolio in Q1 2026.
  • Discovery Value Fund opened 0 new positions and closed 1 in Q1 2026.
  • Discovery Value Fund's portfolio value fell 7.5% quarter-over-quarter to $34.7M.

Based on Discovery Value Fund's 13F filing for Q1 2026, filed 14 May 2026.